Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
McKesson
Express Scripts
Mallinckrodt
Harvard Business School

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209227


Email this page to a colleague

« Back to Dashboard

NDA 209227 describes ABIRATERONE ACETATE, which is a drug marketed by Amneal Pharms, Apotex, Dr Reddys Labs Ltd, Glenmark Pharms, Hikma, MSN, Mylan, Qilu, Rising, Teva Pharms Usa, and Wockhardt Bio Ag, and is included in eleven NDAs. It is available from seventeen suppliers. Additional details are available on the ABIRATERONE ACETATE profile page.

The generic ingredient in ABIRATERONE ACETATE is abiraterone acetate. There are twenty-five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the abiraterone acetate profile page.
Summary for 209227
Tradename:ABIRATERONE ACETATE
Applicant:Glenmark Pharms
Ingredient:abiraterone acetate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 209227
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ABIRATERONE ACETATE abiraterone acetate TABLET;ORAL 209227 ANDA Glenmark Pharmaceuticals Inc., USA 68462-135 68462-135-08 120 TABLET in 1 BOTTLE (68462-135-08)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Oct 16, 2019TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
McKesson
Harvard Business School
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.